Drugs containing this active substance
It is used in adult patients with newly diagnosed low/intermediate-risk acute promyelocytic leukemia (APL) or in adult patients whose disease has not responded to other therapies.
Form: solution for infusion, concentrate
ATC: L01XX27
Manufacturer: TEVA B.V.